PDUFA 2012 – Background From PhRMA’s Perspective
In 2012 Congress will be revisiting Prescription Drug User Fee Act (PDUFA). In an effort to prepare the FDA is asking for comments…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
IMS Reports Significant Global Pharmaceutical Sales Growth in Emerging…
IMS Health reported that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion over the next…
Donald Berwick Nominated CMS Administrator
By adding nearly 31 million more people to the U.S. health care system, the success of Patient Protection and Affordable Care Act…
California Data Mining Bill – Shelved For At Least Another Year
Last week, in our summary of state bills, we summarized AB 2112, a bill that seeks to regulate prescription privacy—in other…
Alzheimer’s Imaging Agents Offer Progress in Diagnosis of an Elusive…
While most doctors, patients, employers and the majority of Americans try to sift through over 2,000 confusing pages of the…
Association of Clinical Researchers and Educators at the American Society…
The American Society of Hypertension is hosting a session at their annual meeting featuring presentations from the Association of…
Prescription for Conflict: CME Funding from Big Pharma to Big Placebo
It seems like every day we run into people and groups who believe in something that scientific evidence has disproved. Often…
CME Helps Physician Compliance
With more and more studies showing that America is going to be facing a significant shortage of physicians in the near…
Massachusetts Meal Ban: Hurts Restaurants, Physicians and Patients
In response to the Massachusetts Code of Conduct which bans restaurant meals at FDA regulated events, Dr. Carlat recently debated…
Journal Supplements: Citation and Peer Review
A recent article in PLOS One, titled “Citability of Original Research and Reviews in Journals and Their Sponsored Supplements,”…